Susquehanna International Group, LLP Exagen Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$2.1 - $3.4 $23,100 - $37,400
-11,000 Reduced 13.41%
71,000 $170,000
Q3 2022

Nov 14, 2022
SELL
$2.69 - $8.68 $140,956 - $454,832
-52,400 Reduced 38.99%
82,000 $222,000
Q2 2022

Aug 15, 2022
BUY
$4.18 - $7.74 $54,757 - $101,394
13,100 Added 10.8%
134,400 $771,000
Q1 2022

May 16, 2022
BUY
$7.12 - $11.06 $863,656 - $1.34 Million
121,300 New
121,300 $974,000

Others Institutions Holding XGN

# of Institutions
38
Shares Held
6.41M
Call Options Held
4.5K
Put Options Held
400
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $89.8M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email